Capital International Investors’s Quest Diagnostics DGX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2018
Q1
Sell
-342,100
Closed -$33.7M 226
2017
Q4
$33.7M Sell
342,100
-960,325
-74% -$91M 0.04% 205
2017
Q3
$122M Sell
1,302,425
-787,575
-38% -$83.6M 0.15% 147
2017
Q2
$232M Hold
2,090,000
0.31% 103
2017
Q1
$205M Hold
2,090,000
0.28% 109
2016
Q4
$192M Sell
2,090,000
-1,110,300
-35% -$95.7M 0.28% 112
2016
Q3
$271M Sell
3,200,300
-81,100
-2% -$6.81M 0.39% 80
2016
Q2
$267M Hold
3,281,400
0.39% 78
2016
Q1
$234M Hold
3,281,400
0.36% 92
2015
Q4
$233M Sell
3,281,400
-3,248,700
-50% -$218M 0.36% 85
2015
Q3
$401M Sell
6,530,100
-243,900
-4% -$17M 0.73% 45
2015
Q2
$491M Buy
6,774,000
+116,400
+2% +$8.59M 0.83% 35
2015
Q1
$512M Hold
6,657,600
0.93% 27
2014
Q4
$446M Buy
6,657,600
+1,394,600
+26% +$88M 0.91% 30
2014
Q3
$319M Buy
5,263,000
+414,800
+9% +$25.6M 0.78% 44
2014
Q2
$285M Hold
4,848,200
0.74% 42
2014
Q1
$281M Buy
4,848,200
+2,223,200
+85% +$119M 0.76% 44
2013
Q4
$141M Buy
2,625,000
+1,645,000
+168% +$97.6M 0.44% 78
2013
Q3
$60.6M Buy
+980,000
New +$58.7M 0.26% 118

Other funds holding DGX

Capital International Investors's DGX Position: Q1 2018 in Review

Capital International Investors sold out of Quest Diagnostics (DGX) in Q1 2018, closing a stake of 342,100 shares — an estimated $33.7M sold.

Capital International Investors first reported a position in DGX in Q3 2013 and held it in 18 quarters. The position peaked at $512M in Q1 2015. 653 funds tracked by Wall St. Rank hold DGX as of Q1 2018.

  • Capital International Investors reported no remaining Quest Diagnostics position as of Q1 2018 after selling out during the quarter.
  • Capital International Investors sold 342,100 Quest Diagnostics shares in Q1 2018, an estimated $33.7M.
  • Capital International Investors first reported a position in Quest Diagnostics in Q3 2013 and held it in 18 quarters.
  • Capital International Investors's Quest Diagnostics position peaked at $512M in Q1 2015.
  • 653 funds tracked by Wall St. Rank held Quest Diagnostics as of Q1 2018.

Based on Capital International Investors's 13F filing for Q1 2018, filed 15 May 2018.